Last updated on September 2020

A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin


Brief description of study

The objective of the current study is to investigate the efficacy and safety of Empagliflozin compared to placebo given for 24 weeks in combination with stable insulin with or without up to two oral antidiabetic drugs in Chinese patients with T2DM with insufficient glycemic control.

Clinical Study Identifier: NCT04233801

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.